Dyne Therapeutics (DYN) Earnings Date & Reports

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases... Show more

Industry: #Electric Utilities

Get AI intraday signals

A.I. Advisor

published Earnings

DYN is expected to report earnings to fall 9.81% to -87 cents per share on October 30

Dyne Therapeutics DYN Stock Earnings Reports

Q3'25

Est.

$-0.87

Q2'25

Missed

by $0.03

Q1'25

Missed

by $0.20

Q4'24

Beat

by $0.06

Q3'24

Missed

by $0.25

The last earnings report on July 28 showed earnings per share of -97 cents, missing the estimate of -93 cents. With 14.27M shares outstanding, the current market capitalization sits at 1.65B.

View a ticker or compare two or three

Compare

DYN